Cohera Medical in Midst of U.S. Clinical Trials

Posted on 8/20/2012 8:26:46 AM By Pittsburgh Business Times; Malia Spencer

Pittsburgh-based Cohera Medical has completed patient enrollment in U.S. clinical trials for its surgical adhesive TissuGlu, marking a key step in the company’s U.S. commercialization effort. TissuGlu already is on sale and in use in Germany and has been used in more than 500 procedures. The product is used in large flap surgeries called abdominoplasty, or tummy-tucks, and helps reduce post-surgery complications due to fluid that can accumulate.

Abstract News © Copyright 2012 INFORMATION, INC.